Development of experimental Parkinsonism:
Generating the disease models with predictive validity, to explore potential neuroprotectiveand  regenerative therapies for PD

 Pharmacogenetic and genomic screenings for PD and PD-like disorders [such as   spinocerebellar ataxia (SCA)]